Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
2001 2
2002 1
2008 1
2009 1
2010 1
2013 1
2017 2
2019 2
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria.
Dickey AK, Naik H, Keel SB, Levy C, Beaven SW, Elmariah SB, Erwin AL, Goddu RJ, Hedstrom K, Leaf RK, Kazamel M, Mazepa M, Philpotts LL, Quigley J, Raef H, Rudnick SR, Saberi B, Thapar M, Ungar J, Wang B, Balwani M; Porphyrias Consortium of the Rare Diseases Clinical Research Network. Dickey AK, et al. J Am Acad Dermatol. 2023 Dec;89(6):1227-1237. doi: 10.1016/j.jaad.2022.08.036. Epub 2022 Aug 27. J Am Acad Dermatol. 2023. PMID: 36041558
Finally, management of pregnancy and surgery and the safety of other therapies are summarized. We emphasize that these are multisystemic disorders that require longitudinal monitoring. ...Early diagnosis and management of these disorders are essential, particularly given t …
Finally, management of pregnancy and surgery and the safety of other therapies are summarized. We emphasize that these are multisyste …
Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management.
Balwani M. Balwani M. Mol Genet Metab. 2019 Nov;128(3):298-303. doi: 10.1016/j.ymgme.2019.01.020. Epub 2019 Jan 24. Mol Genet Metab. 2019. PMID: 30704898 Free PMC article. Review.
Treatment is limited to sun-protection and there are no currently available FDA-approved therapies for these disorders. Afamelanotide, a synthetic analogue of alpha-melanocyte stimulating hormone was found to increase pain-free sun exposure and improve quality of life in a …
Treatment is limited to sun-protection and there are no currently available FDA-approved therapies for these disorders. Afamelanotide …
Cutaneous allergic drug reactions: update on pathophysiology, diagnostic procedures and differential diagnosic.
Balakirski G, Merk HF. Balakirski G, et al. Cutan Ocul Toxicol. 2017 Dec;36(4):307-316. doi: 10.1080/15569527.2017.1319379. Epub 2017 Apr 27. Cutan Ocul Toxicol. 2017. PMID: 28412864 Review.
Finally, some special aspects of side effects of biologics and targeted therapies respectively are discussed....
Finally, some special aspects of side effects of biologics and targeted therapies respectively are discussed....
Into the Light: Afamelanotide and the Treatment of Erythropoietic Protoporphyria in the United States.
Resnik SR, Targett D, Resnik BI. Resnik SR, et al. J Drugs Dermatol. 2023 Sep 1;22(9):941-949. doi: 10.36849/JDD.7126. J Drugs Dermatol. 2023. PMID: 37683058
Outcomes measured included: return to normal activities, experience of phototoxic reactions, effect on patient confidence, and more. Patients ranked their experience on a descriptive scale ranging from "very much" to "never". ...
Outcomes measured included: return to normal activities, experience of phototoxic reactions, effect on patient confidence, and more. …
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
Moore DE. Moore DE. Drug Saf. 2002;25(5):345-72. doi: 10.2165/00002018-200225050-00004. Drug Saf. 2002. PMID: 12020173 Review.
Adverse photosensitivity responses to drugs occur predominantly as a phototoxic reaction which is more immediate than photoallergy, and can be reversed by withdrawal or substitution of the drug. ...In the antibacterial drug class, the tetracyclines, fluoroquinolones and su …
Adverse photosensitivity responses to drugs occur predominantly as a phototoxic reaction which is more immediate than photoallergy, a …
Diagnosis and treatment of allergic skin disorders in the elderly.
Nedorost ST, Stevens SR. Nedorost ST, et al. Drugs Aging. 2001;18(11):827-35. doi: 10.2165/00002512-200118110-00004. Drugs Aging. 2001. PMID: 11772123 Review.
Although elderly people have somewhat decreased cell-mediated immunity and may be harder to sensitise under experimental conditions, they have had many years to acquire allergic responses, and therefore develop contact dermatitis frequently. Patch testing is a valuable too …
Although elderly people have somewhat decreased cell-mediated immunity and may be harder to sensitise under experimental conditions, they ha …
Phototoxic risk assessment on benzophenone UV filters: In vitro assessment and a theoretical model.
Xiong L, Tang J, Li Y, Li L. Xiong L, et al. Toxicol In Vitro. 2019 Oct;60:180-186. doi: 10.1016/j.tiv.2019.05.021. Epub 2019 May 30. Toxicol In Vitro. 2019. PMID: 31154060
Benzophenones (BPs), filtering out both UVA and UVB rays, are widely used in a great variety of sunscreens and personal care products. However, they have not been extensively studied for the mechanisms of UV-absorbing toxicity. ...It was found that Balb/c 3T3 (Balb/c 3T3 f …
Benzophenones (BPs), filtering out both UVA and UVB rays, are widely used in a great variety of sunscreens and personal care products …
Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis.
Bekersky I, Fitzsimmons W, Tanase A, Maher RM, Hodosh E, Lawrence I. Bekersky I, et al. J Am Acad Dermatol. 2001 Jan;44(1 Suppl):S17-27. doi: 10.1067/mjd.2001.109816. J Am Acad Dermatol. 2001. PMID: 11145792 Review.
Tacrolimus ointment, formulated for the treatment of atopic dermatitis, is the first in a class of topical immunomodulators. Its mechanism of action is based on calcineurin inhibition, which results in suppression of antigen-specific T-cell activation and inhibition of inf …
Tacrolimus ointment, formulated for the treatment of atopic dermatitis, is the first in a class of topical immunomodulators. Its mech …
19 results